Table 8.
Survival analysis of three treatments on four BIC subtypes and three GBM subtypes
| Treatment | All | Subtype1 | Subtype2 | Subtype3 | Subtype4 |
|---|---|---|---|---|---|
| Cytoxan(BIC) | 3.3e-02 | 6.1e-01 | 4.5e-02 | 4.83e-01 | 5.01e-01 |
| Adriamycin(BIC) | 1.3e-02 | 2.77e-01 | 3.2e-02 | 8.21e-01 | 2.66e-01 |
| Temozolomide(GBM) | 3.6e-02 | 2.0e-02 | 9.18e-01 | 3.88e-01 | —— |
The treatment can significantly improve treatment outcomes in the subtype of p-value in boldface